Abbott Labs Wins FDA Approval For MitraClip Implant

Law360, New York (October 25, 2013, 5:35 PM EDT) -- Abbott Laboratories won the green light from U.S. medical device regulators for its MitraClip implantable heart device, which is marketed as a less invasive way to treat heart valve defects, the health care products giant said Friday. 

The U.S. Food and Drug Administration has approved the MitraClip treatment, which would be among of the first of its kind of device sold in the U.S., for patients with serious mitral regurgitation — a health condition where the mitral valve doesn't fully close — and for whom surgery...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.